Melissa Geller, MD
Enriched profileProfessor and Department Executive Vice Chair, Division of Gynecologic Oncology · University of Minnesota Medical School
Melissa Geller is Professor and Department Executive Vice Chair, Division of Gynecologic Oncology at University of Minnesota Medical School. OpenAlex indexes 257 publications with 8,854 citations (h-index 47); ClinicalTrials.gov lists 19 registered studies with this person as an investigator.
Data verified 14 Aug 2026
Overview
Updated 27 Aug 2026
Melissa Geller, MD, is Professor and Department Executive Vice Chair, Division of Gynecologic Oncology at University of Minnesota Medical School, Department of Obstetrics, Gynecology and Women's Health. The public record shows 257 publications with 8,854 citations (h-index 47), centered on Breast Cancer, Ovarian / Gynecologic Cancer. It also documents an investigator role on 19 registered clinical trials, industry payments reported by 5 companies, 3 NIH-funded awards (2009–2026).
- Most recent indexed publication: 2025 · Journal for immunotherapy of cancer
- Top research focus: Breast Cancer
- 19 registered trials on ClinicalTrials.gov
- Open Payments reporting from 5 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 8 in PubMed.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 19 registered studies on ClinicalTrials.gov. The most recent:
- Signatera Assessment in Early-Stage Endometrial Cancer
Sponsor: Natera, Inc.
- A Study to Evaluate the Safety and Efficacy of OPB-101 in Platinum-resistant Ovarian Cancer
Sponsor: Outpace Bio, Inc.
Industry payments
Updated 27 Aug 2026
5 companies reported payments to CMS in program years 2023–2025. These are public disclosures, not judgments. The latest:
- Medtronic, Inc.Program year20251 payment
- Merck Sharp & Dohme LLCProgram year20241 payment
- GlaxoSmithKline, LLC.Program year20234 payments
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
50%Corticosteroid50%Dexamethasone100%Part D<11 patientsNervous system
50%SSRI50%Fluoxetine Hcl100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 27 Aug 2026
3 NIH research awards on record, funded 2009–2026 per NIH RePORTER. The latest:
- Locally Targeted Off-The-Shelf NK Cells For Ovarian Cance
University of Minnesota
FY2025$387,581P01CA111412
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- TGF-βRII/IL-15 immunotherapeutic complex targets exhausted CD8(+) T-cell subsets in lymph nodes and tumors.
Journal for immunotherapy of cancer
Article2025 - Assessment of Active Cytomegalovirus (CMV) and Epstein-Barr Virus (EBV) Infections and Patient Reported Fatigue in Ovarian Cancer Survivors.
Cancer reports (Hoboken, N.J.)
Article2025 - HSD3B1 (c.1100C) Genotype Is Associated with Distinct Tumoral and Clinical Outcomes in Breast and Endometrial Cancers.
International journal of molecular sciences
Article2025 - Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of gynecologic cancer.
Journal for immunotherapy of cancer
Guideline2023 - Reverse Translation Identifies the Synergistic Role of Immune Checkpoint Blockade and IL15 to Enhance Immunotherapy of Ovarian Cancer.
Cancer immunology research
Article2023
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/melissa-geller-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - ResearchGate
researchgate.net/scientific-contributions/Melissa-A-Geller-39847967
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗
Mentions by others
where others cite or feature them- Facebook
facebook.com/umnmedschool/videos/dr-melissa-geller-in-the-umn-department-of-obstetrics-gynecology-and-womens-heal/333918560729416
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →facebook.com ↗ - Facebook
facebook.com/umphysicians/posts/dr-melissa-geller-m-physicians-gynecologic-oncologist-was-a-featured-presenter-d/2826433624033920
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →facebook.com ↗ - Other
mnovarian.org/dr-melissa-geller
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mnovarian.org ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →med.umn.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →providers.mhealthfairview.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →providers.mhealthfairview.org ↗
- Fellowship
Gynecologic Oncology, University of Minnesota / Memorial Sloan Kettering Cancer Center (Galloway Fellowship)
2005verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.umn.edu ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.umn.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.umn.edu ↗
Editorial & leadership roles
journal and society appointments- Member
NRG Oncology Developmental Therapeutics/Phase I Committee
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.umn.edu ↗ - Member
NRG Oncology Ovarian Committee
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.umn.edu ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.umn.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.umn.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.umn.edu ↗
Secondary affiliations
appointments beyond the home institution- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.umn.edu ↗
- Associate Director of Clinical Research
University of Minnesota Masonic Cancer Center
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.umn.edu ↗ - Director
Translational Working Group in Gynecologic Cancers
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.umn.edu ↗
Media & interviews
press, podcasts and appearances- "Dr. Melissa Geller Encourages International Partnerships in Ovarian Cancer Research Through Fulbright Scholarship"
University of Minnesota Medical School news feature
2024verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.umn.edu ↗ - "Voices: Is there a 'good' time to start a family as a gynecologic oncologist?"
first-person essay, Society of Gynecologic Oncology blog
2018
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Daniel Weisdorf, MD
University of Minnesota Medical School
Jeffrey Miller, MD
University of Minnesota Medical School
Emmanuel Antonarakis, MD
University of Minnesota Medical School
David Boulware, MD, MPH
University of Minnesota Medical School